Let us start by saying that the “new name” for this type of pneumonia is called PJP (Pneumocystis Jirovecii Pneumonia) and it is NOT called PCP.
This is because P. jirovecii infects humans, while P. carinni infects rats. The other important fact to keep in mind is that the micro-organism is a FUNGUS, NOT a protozoa (this has been known since around 1988). It is mostly found in immunocompromised patients. It may be transmitted from person to person via the airborne route. Similar to Tuberculosis, patients that are immunocompetent may be infected with PJP. However, these patients will not develop the “disease”. These patients remain asymptomatic, and they may become asymptomatic carriers. This is an AIDS defining illness.
It is important to remember that ANY patient who is immunocompromised may be affected. However, it is worth noting that patients who are HIV infected with a CD4+ count < 200 are at high risk of acquiring PJP. This is the reason why these patients should be started on primary prophylaxis.
Risk Factors: Primary and Secondary Immunosuppressive conditions (Malignancy, HIV, Transplant Recipients, Immunosuppressive Treatment, Steroids)
Once the fungi attaches itself to the alveolar epithelium, the host response causes significant lung injury which results in impaired gas exchange. (Reason why they desaturate).
Patients typically present with several weeks of:
Only start treatment once a diagnosis is made. However, you may inititate treatment in patients that have risk factors and have features which suggests PJP.
Made with ❤️ by QuickBeat
We are a small education agency that aims to provide medical education.